Trials / Terminated
TerminatedNCT00114946
A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer
A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 800 (planned)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, open-label, active-control, multicenter trial comparing two oxaliplatin/Avastin-based treatment sequences as first-line therapy for metastatic colorectal cancer. The study is designed to compare the efficacy of these two treatment sequences with respect to progression free survival (PFS) and overall survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avastin |
Timeline
- Start date
- 2005-05-01
- Completion
- 2007-12-01
- First posted
- 2005-06-21
- Last updated
- 2006-05-29
Source: ClinicalTrials.gov record NCT00114946. Inclusion in this directory is not an endorsement.